Alberto Zambelli

29PUBLICATIONS
157CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Data mining and knowledge discoveryLiquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jan 26, 2026
Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial.

Giampaolo Bianchini, Luca Malorni, Roberta Caputo

|Jan 09, 2026
Subcutaneous Immunotherapy in Cancer: Where We Are Now, What It Changes, and What to Watch Next.

Fausto Petrelli, Alessandro Iaculli, Alberto Zambelli

|Nov 06, 2025
Longitudinal Synthetic Data Generation by Artificial Intelligence to Accelerate Clinical and Translational Research in Breast Cancer.

Elena Zazzetti, Saverio D'Amico, Flavia Jacobs

|Aug 20, 2025
The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

Andrea Botticelli, Chiara Cremolini, Simone Scagnoli

|Jun 12, 2025
Pre-existing and emerging immune-mediated diseases in patients with breast cancer undergoing cyclin-dependent kinases 4/6 inhibitors and endocrine therapy.

Flavia Jacobs, Mariangela Gaudio, Chiara Andreottola

|May 14, 2025
Decoding NATALEE and MonarchE eligibility criteria in a real-world cohort of early breast cancer patients.

Jacopo Canzian, Damiano Gentile, Rita De Sanctis

Pageof 5

Frequent Collaborators

16 joint publications

Rita De Sanctis

11 joint publications

Flavia Jacobs

9 joint publications

Armando Santoro

8 joint publications

Paola Tiberio